Prediction of African Swine Fever Virus Inhibitors by Molecular Docking-Driven Machine Learning Models.

Journal: Molecules (Basel, Switzerland)
PMID:

Abstract

African swine fever virus (ASFV) causes a highly contagious and severe hemorrhagic viral disease with high mortality in domestic pigs of all ages. Although the virus is harmless to humans, the ongoing ASFV epidemic could have severe economic consequences for global food security. Recent studies have found a few antiviral agents that can inhibit ASFV infections. However, currently, there are no vaccines or antiviral drugs. Hence, there is an urgent need to identify new drugs to treat ASFV. Based on the structural information data on the targets of ASFV, we used molecular docking and machine learning models to identify novel antiviral agents. We confirmed that compounds with high affinity present in the region of interest belonged to subsets in the chemical space using principal component analysis and -means clustering in molecular docking studies of FDA-approved drugs. These methods predicted pentagastrin as a potential antiviral drug against ASFVs. Finally, it was also observed that the compound had an inhibitory effect on PolX activity. Results from the present study suggest that molecular docking and machine learning models can play an important role in identifying potential antiviral drugs against ASFVs.

Authors

  • Jiwon Choi
    Bioinformatics & Molecular Design Research Center, Yonsei University, Seoul 03722, South Korea.
  • Jun Seop Yun
    Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul 03722, Korea.
  • Hyeeun Song
    Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul 03722, Korea.
  • Yong-Keol Shin
    Enzynomics Co. Ltd., Yuseong-gu, Daejeon 34050, Korea.
  • Young-Hoon Kang
    Enzynomics Co. Ltd., Yuseong-gu, Daejeon 34050, Korea.
  • Palinda Ruvan Munashingha
    Enzynomics Co. Ltd., Yuseong-gu, Daejeon 34050, Korea.
  • Jeongyeon Yoon
    Enzynomics Co. Ltd., Yuseong-gu, Daejeon 34050, Korea.
  • Nam Hee Kim
    Preventive Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Hyun Sil Kim
    Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul 03722, Korea.
  • Jong In Yook
    Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul 03722, Korea.
  • Dongseob Tark
    Laboratory for Infectious Disease Prevention, Korea Zoonosis Research Institute, Jeonbuk National University, Iksan 54596, Korea.
  • Yun-Sook Lim
    Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University, Iksan 54596, Korea.
  • Soon B Hwang
    Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University, Iksan 54596, Korea.